Fair values of financial instruments carried at fair value (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Measurement [Abstract] |
|
| Disclosure of fair value measurement of assets |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
There were no material transfers between Level 1 and Level 2 during the reporting period. The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 15. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2026 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives measured at fair value through profit or loss | | | | | | | | | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the current year and ‘exchange differences’ in the consolidated statement of comprehensive income. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value on the balance sheet – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of fair value measurement of liabilities |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
There were no material transfers between Level 1 and Level 2 during the reporting period. The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 15. | | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2026 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total gains or losses recognised in profit or loss | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | | | | | | | | | Total gains/(losses) recognised in other comprehensive income (‘OCI’)1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains or losses recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – net income or losses from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives measured at fair value through profit or loss | | | | | | | | | | | | | | | |
1Included in ‘financial investments: fair value gains/(losses)’ in the current year and ‘exchange differences’ in the consolidated statement of comprehensive income. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value on the balance sheet – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of the effect of changes in significant unobservable assumptions to reasonably possible alternatives, assets |
The following table shows the sensitivity of Level 3 fair values to reasonably possible alternative assumptions: | | | | | Sensitivity of fair values to reasonably possible alternative assumptions | | Reflected in profit or loss | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | |
1‘Derivatives, trading assets and trading liabilities’ are presented as one category to reflect the manner in which these financial instruments are risk-managed.
|
| Disclosure of the effect of changes in significant unobservable assumptions to reasonably possible alternatives, liabilities |
The following table shows the sensitivity of Level 3 fair values to reasonably possible alternative assumptions: | | | | | Sensitivity of fair values to reasonably possible alternative assumptions | | Reflected in profit or loss | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | |
1‘Derivatives, trading assets and trading liabilities’ are presented as one category to reflect the manner in which these financial instruments are risk-managed.
|
| Disclosure of significant unobservable inputs used in fair value measurement of assets |
The following table lists key unobservable inputs to Level 3 financial instruments and provides the range of those inputs at 30 June 2026. There has been no change to the key unobservable inputs to Level 3 financial instruments and inter-relationships therein, which are detailed on pages 336 and 337 of the Annual Report and Accounts 2025 on Form 20-F. | | | | | | | | | Quantitative information about significant unobservable inputs in Level 3 valuations | | | | | | | | | | | | | | | | | | | Private equity including strategic investments1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – foreign exchange-linked notes | | | | | | | | | | | | | | | | | | | | | | | | | | | – interest rate derivatives | | | | | | | | | | | | Model – Discounted cash flow | | | | | | | | | | | | | | | other interest rate derivatives | | | | | | | | | – foreign exchange derivatives | | | | | | | | | | | | | | | | | | other foreign exchange derivatives | | | | | | | | | | | | | | | | | | long-dated single stock options | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1‘Private equity including strategic investments’ includes private equity, private credit and private equity fund, primarily held as part of our Insurance business and for strategic investments. 2‘Other portfolios’ includes a range of smaller asset holdings.
|
| Disclosure of significant unobservable inputs used in fair value measurement of liabilities |
The following table lists key unobservable inputs to Level 3 financial instruments and provides the range of those inputs at 30 June 2026. There has been no change to the key unobservable inputs to Level 3 financial instruments and inter-relationships therein, which are detailed on pages 336 and 337 of the Annual Report and Accounts 2025 on Form 20-F. | | | | | | | | | Quantitative information about significant unobservable inputs in Level 3 valuations | | | | | | | | | | | | | | | | | | | Private equity including strategic investments1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – foreign exchange-linked notes | | | | | | | | | | | | | | | | | | | | | | | | | | | – interest rate derivatives | | | | | | | | | | | | Model – Discounted cash flow | | | | | | | | | | | | | | | other interest rate derivatives | | | | | | | | | – foreign exchange derivatives | | | | | | | | | | | | | | | | | | other foreign exchange derivatives | | | | | | | | | | | | | | | | | | long-dated single stock options | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1‘Private equity including strategic investments’ includes private equity, private credit and private equity fund, primarily held as part of our Insurance business and for strategic investments. 2‘Other portfolios’ includes a range of smaller asset holdings.
|